Fragmentation resistant IgG1 Fc-conjugates

Details for Australian Patent Application No. 2010239216 (hide)

Owner Amgen Inc.

Inventors Yan, Boxu; Hu, Zhonghua; Kleemann, Gerd Richard; Yates, Zachary Adam; Zhou, Hongxing

Agent Shelston IP

Pub. Number AU-B-2010239216

PCT Pub. Number WO2010/124018

Priority 61/171,393 21.04.09 US

Filing date 21 April 2010

Wipo publication date 28 October 2010

Acceptance publication date 12 July 2012

International Classifications

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

27 October 2011 PCT application entered the National Phase

  PCT publication WO2010/124018 Priority application(s): WO2010/124018

12 July 2012 Application Accepted

  Published as AU-B-2010239216

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010239219-Communication interface for sensory stimulation

2010239214-Artificial intelligence-assisted medical reference system and method